Coinbase Global, Bristol-Myers Squibb And 2 Other Stocks Insiders Are Selling
Portfolio Pulse from Lisa Levin
Insider sales were reported at Bristol-Myers Squibb (BMY), Schlumberger (SLB), Coinbase Global (COIN), and The Andersons (ANDE). These sales could indicate concerns about the companies' prospects or overpricing of the stocks. BMY's Reblozyl was approved by the FDA for initial anemia treatment. SLB secured a five-year contract from Petrobras. COIN acquired an equity stake in Circle, the co-founder of the USD Coin. ANDE announced a Q4 2023 cash dividend.
August 29, 2023 | 12:32 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Insider sale at The Andersons, which announced a Q4 2023 cash dividend.
The insider sale might suggest concerns, but the dividend announcement is a positive factor.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Insider sale at Bristol-Myers Squibb amid FDA approval of Reblozyl.
While the insider sale could indicate concerns, the FDA approval of Reblozyl is a positive development.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Insider sale at Coinbase Global as the company acquires an equity stake in Circle.
The insider sale could indicate concerns, but the equity stake acquisition in Circle is a positive move.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Insider sale at Schlumberger following a contract win from Petrobras.
The insider sale might suggest concerns, but the contract win from Petrobras is a positive signal.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100